A recent analysis ranked Amgen Inc (NYSE: AMGN) as the 17th pick among 30 stocks in the Dow Jones Industrial Average, according to ETF Channel. While this places Amgen below the median in the Dow, it ranks higher within the broader S&P 500, coming in at 195th out of 500 companies.
As of midday Tuesday, AMGN shares are trading up approximately 1.2%. In the biotechnology sector, competitors Thermo Fisher Scientific Inc (TMO) and Gilead Sciences Inc (GILD) are experiencing declines of about 1.8% and 0.3%, respectively.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
